Literature DB >> 12766614

Microsatellite instability and p53 expression in gallbladder carcinomas.

Fausto Sessa1, Daniela Furlan, Anna Genasetti, Paola Billo, Maddalena Feltri, Carlo Capella.   

Abstract

We studied the MSI (microsatellite instability) status and p53 expression in a series of 71 gallbladder cancers (GCs) of different histologic type. All neoplasms were examined combining a microsatellite analysis at mononucleotide locus BAT-26 and an immunohistochemical study for hMSH2, hMLH1, and p53 proteins and markers of gastric and intestinal differentiation. All the 71 GCs were MSS (microsatellite stable). The p53 protein was found in 100% of undifferentiated GCs, 67% of conventional gallbladder adenocarcinomas, 50% of mucinous adenocarcinomas, and 20% GCs with squamous differentiation. All 71 MSS tumors showed presence of immunohistochemical expression of both hMLH1 and hMSH2 gene products. We concluded that microsatellite instability does not play a role in the developing of GC while p53 seems to be the most important alteration found in a large proportion of these cancers, with the only exception of mucinous and squamous gallbladder carcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766614     DOI: 10.1097/00019606-200306000-00005

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  8 in total

1.  Microsatellite instability in gallbladder carcinoma.

Authors:  Andrea P Moy; Mohammad Shahid; Cristina R Ferrone; Darrell R Borger; Andrew X Zhu; David Ting; Vikram Deshpande
Journal:  Virchows Arch       Date:  2015-02-14       Impact factor: 4.064

Review 2.  Cyclooxygenase-2, p53 and glucose transporter-1 as predictors of malignancy in the development of gallbladder carcinomas.

Authors:  Mateja Legan
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

3.  Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability.

Authors:  Angelica A Saetta; Pollyanthi Papanastasiou; Nikolaos V Michalopoulos; Fanie Gigelou; Penelope Korkolopoulou; Thaleia Bei; Efstratios Patsouris
Journal:  Virchows Arch       Date:  2004-06-19       Impact factor: 4.064

4.  Deregulation of MYC and TP53 through genetic and epigenetic alterations in gallbladder carcinomas.

Authors:  Geraldo Ishak; Mariana Ferreira Leal; Ney Pereira Carneiro Dos Santos; Samia Demachki; Caroline Aquino Moreira Nunes; Barbara do Nascimento Borges; Danielle Queiroz Calcagno; Marília Cardoso Smith; Paulo Pimentel Assumpção; Rommel Rodríguez Burbano
Journal:  Clin Exp Med       Date:  2014-09-09       Impact factor: 3.984

5.  Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.

Authors:  Elena Czink; Matthias Kloor; Benjamin Goeppert; Stefan Fröhling; Sebastian Uhrig; Tim F Weber; Jörn Meinel; Christian Sutter; Karl Heinz Weiss; Peter Schirmacher; Magnus von Knebel Doeberitz; Dirk Jäger; Christoph Springfeld
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-09-01

6.  Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study.

Authors:  Fátima Ramalhosa; Maria João Amaral; Marco Serôdio; Rui Caetano Oliveira; Paulo Teixeira; Maria Augusta Cipriano; José Guilherme Tralhão
Journal:  J Gastrointest Oncol       Date:  2022-08

7.  Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy.

Authors:  Jing Yu; Xi Zhang; Qiyue Huang; Sirui Tan; Xianze Xiong; Hongfeng Gou
Journal:  Cancer Manag Res       Date:  2021-05-31       Impact factor: 3.989

8.  Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma.

Authors:  You-Na Sung; Sung Joo Kim; Sun-Young Jun; Changhoon Yoo; Kyu-Pyo Kim; Jae Hoon Lee; Dae Wook Hwang; Shin Hwang; Sang Soo Lee; Seung-Mo Hong
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.